[1]
H. W. NUR’AMIN, I. Dwiprahasto, and E. Kristin, “EFFECTIVENESS OF TICAGRELOR COMPARED TO CLOPIDOGREL IN REDUCING THE RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE AFTER PERCUTANEOUS CORONARY INTERVENTION”, Int J Pharm Pharm Sci, vol. 9, no. 9, pp. 178–183, Sep. 2017.